Department of Clinical Sciences, Lund
7831 – 7840 of 34443
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
(
- Contribution to journal › Article
-
Mark
No-touch saphenous vein grafts in coronary artery surgery (SWEDEGRAFT) : Rationale and design of a multicenter, prospective, registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
A pilot proteomic study reveals different protein profiles related to testosterone and gonadotropin changes in a short-term controlled healthy human cohort
(
- Contribution to journal › Letter
-
Mark
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial
(
- Contribution to journal › Article
-
Mark
New revision of the 25-year-old CEAP classification is timely and warranted
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Morphine affects brain activity and volumes in preterms : An observational multi-center study
(
- Contribution to journal › Article
-
Mark
Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI
(
- Contribution to journal › Article
-
Mark
Inner ear is a target for insulin signaling and insulin resistance : evidence from mice and auditory HEI-OC1 cells
(
- Contribution to journal › Article
-
Mark
Obstructive sleep apnoea in acute coronary syndrome
(
- Contribution to journal › Letter
-
Mark
Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction : A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article